Aligos Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, announced that a poster describing data from the ongoing Study ALG-000184-201 will be presented at the HBV-TAG 2021 Conference, taking place virtually June 11-12, 2021.
June 10, 2021
· 5 min read